PMA device
PearlMatrix P-15 Peptide Enhanced Bone Graft (PearlMatrix Bone Graft)
Cerapedics, Inc. · Filler, Bone Void, Synthetic Peptide (NOX, Class III) · First FDA decision Dec 11, 2025, newest Dec 11, 2025
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "PearlMatrix P-15"
MAUDE reports
0
Brand "PearlMatrix P-15", since 2015
PubMed studies
0
Mentioning "PearlMatrix P-15"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing PearlMatrix P-15 Peptide Enhanced Bone Graft (PearlMatrix Bone Graft)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P240001-S001 · Decided Dec 11, 2025 · 94 days after receipt · Normal 180 Day Track
Device type: Filler, bone void, synthetic peptide (NOX) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "PearlMatrix P-15", any status and sponsor, newest update first.
No registered device study names "PearlMatrix P-15".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "PearlMatrix P-15", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NOX
178 reports: 7 malfunction, 171 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1165-2026 · Started Dec 29, 2025 · Posted by FDA Jan 23, 2026
Reason given: Incorrect expiration date
Cause as FDA categorized it: Labeling Change Control · Device type: Filler, Bone Void, Synthetic Peptide (NOX)
Published research
The most relevant PubMed records for "PearlMatrix P-15"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NOX.
- Augment® Bone GraftBiomimetic Therapeutics, LLC · PMA 2022
- i-FACTOR® Peptide Enhanced Bone GraftCerapedics, LLC · PMA 2024
- AUGMENT InjectableBiomimetic Therapeutics, LLC · PMA 2019
- PearlMatrix Bone GraftCerapedics, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.